Torii Pharmaceutical Co., Ltd.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a TRXPF research report →
Price Chart
About the company
Torii Pharmaceutical Co. , Ltd. , a Tokyo-based Japanese firm established in 1872, specializes in the development and commercialization of a variety of pharmaceutical products.
- CEO
- Goichi Matsuda
- IPO
- 2013
- Employees
- 583
- HQ
- Tokyo, JP
Get TickerSpark's AI analysis on TRXPF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $690.70M
- P/E
- 35.40
- Fwd P/E
- 0.21
- PEG
- 12.08
- P/S
- 2.95
- P/B
- 1.47
- EV/EBITDA
- 21.34
- Div Yield
- 0.94%
- Gross Margin
- 43.86%
- Op Margin
- 11.25%
- Net Margin
- 8.34%
- ROE
- 4.17%
- ROIC
- 4.16%
Latest fiscal year · YoY change
- Revenue
- $60.42B+10.6%
- Gross Profit
- $26.71B+17.4%
- Op Income
- $6.80B
- Net Income
- $5.04B+22.4%
- EPS
- $179.46+22.4%
- OCF Growth
- +216.5%
- FCF Growth
- +203.6%
- 52W High
- $24.57
- 52W Low
- $24.57
- Beta
- 0.33
- RSI (14)
- 100
- Avg Volume
- 0
No earnings-call transcripts are available for TRXPF yet.
- Free Float
- 4.1%
- Shares Outstanding
- 28.11M
- Float Shares
- 1.14M
Our TRXPF coverage
Recent articles, reports, and earnings notes.
No research on TRXPF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate TRXPF report →